QQQ   318.40 (-1.60%)
AAPL   125.12 (-2.09%)
MSFT   233.87 (-1.30%)
FB   259.00 (-2.23%)
GOOGL   2,064.48 (-0.25%)
TSLA   686.44 (-4.45%)
AMZN   3,094.53 (-1.64%)
NVDA   536.25 (-3.15%)
BABA   234.42 (-3.01%)
CGC   35.25 (+1.50%)
GE   12.98 (-0.99%)
MU   91.09 (-3.87%)
NIO   43.29 (-13.00%)
AMD   84.13 (-2.62%)
T   28.22 (+0.46%)
F   12.55 (+4.76%)
ACB   11.03 (-0.09%)
DIS   193.94 (-0.53%)
BA   223.14 (-0.56%)
NFLX   547.82 (-0.51%)
PFE   33.51 (-0.53%)
QQQ   318.40 (-1.60%)
AAPL   125.12 (-2.09%)
MSFT   233.87 (-1.30%)
FB   259.00 (-2.23%)
GOOGL   2,064.48 (-0.25%)
TSLA   686.44 (-4.45%)
AMZN   3,094.53 (-1.64%)
NVDA   536.25 (-3.15%)
BABA   234.42 (-3.01%)
CGC   35.25 (+1.50%)
GE   12.98 (-0.99%)
MU   91.09 (-3.87%)
NIO   43.29 (-13.00%)
AMD   84.13 (-2.62%)
T   28.22 (+0.46%)
F   12.55 (+4.76%)
ACB   11.03 (-0.09%)
DIS   193.94 (-0.53%)
BA   223.14 (-0.56%)
NFLX   547.82 (-0.51%)
PFE   33.51 (-0.53%)
QQQ   318.40 (-1.60%)
AAPL   125.12 (-2.09%)
MSFT   233.87 (-1.30%)
FB   259.00 (-2.23%)
GOOGL   2,064.48 (-0.25%)
TSLA   686.44 (-4.45%)
AMZN   3,094.53 (-1.64%)
NVDA   536.25 (-3.15%)
BABA   234.42 (-3.01%)
CGC   35.25 (+1.50%)
GE   12.98 (-0.99%)
MU   91.09 (-3.87%)
NIO   43.29 (-13.00%)
AMD   84.13 (-2.62%)
T   28.22 (+0.46%)
F   12.55 (+4.76%)
ACB   11.03 (-0.09%)
DIS   193.94 (-0.53%)
BA   223.14 (-0.56%)
NFLX   547.82 (-0.51%)
PFE   33.51 (-0.53%)
QQQ   318.40 (-1.60%)
AAPL   125.12 (-2.09%)
MSFT   233.87 (-1.30%)
FB   259.00 (-2.23%)
GOOGL   2,064.48 (-0.25%)
TSLA   686.44 (-4.45%)
AMZN   3,094.53 (-1.64%)
NVDA   536.25 (-3.15%)
BABA   234.42 (-3.01%)
CGC   35.25 (+1.50%)
GE   12.98 (-0.99%)
MU   91.09 (-3.87%)
NIO   43.29 (-13.00%)
AMD   84.13 (-2.62%)
T   28.22 (+0.46%)
F   12.55 (+4.76%)
ACB   11.03 (-0.09%)
DIS   193.94 (-0.53%)
BA   223.14 (-0.56%)
NFLX   547.82 (-0.51%)
PFE   33.51 (-0.53%)
Log in
NASDAQ:ATHA

Athira Pharma News Headlines

$20.85
-0.55 (-2.57 %)
(As of 03/2/2021 12:00 AM ET)
Add
Compare
Today's Range
$20.09
Now: $20.85
$21.40
50-Day Range
$20.06
MA: $22.73
$27.99
52-Week Range
$15.79
Now: $20.85
$34.79
Volume324,328 shs
Average Volume475,603 shs
Market Capitalization$677.31 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Athira Pharma (NASDAQ ATHA) News Headlines Today

Source:
SourceHeadline
Athira Pharma to Present at H.C. Wainwright & Co. Global Life Sciences ConferenceAthira Pharma to Present at H.C. Wainwright & Co. Global Life Sciences Conference
finance.yahoo.com - March 2 at 9:46 AM
Athira Pharma (NASDAQ:ATHA) Stock Price Up 10.1%Athira Pharma (NASDAQ:ATHA) Stock Price Up 10.1%
americanbankingnews.com - February 22 at 7:00 PM
Athira Pharma Announces Exercise of Underwriters Option to Purchase Additional SharesAthira Pharma Announces Exercise of Underwriters' Option to Purchase Additional Shares
marketwatch.com - February 11 at 1:35 PM
Athira Pharma Announces Exercise of Underwriters’ Option to Purchase Additional SharesAthira Pharma Announces Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - February 10 at 7:28 PM
Athira Pharma (NASDAQ:ATHA) Trading 8.9% Higher Athira Pharma (NASDAQ:ATHA) Trading 8.9% Higher
americanbankingnews.com - February 8 at 8:14 PM
Why Athira Pharma Stock Dropped TodayWhy Athira Pharma Stock Dropped Today
finance.yahoo.com - January 24 at 12:13 AM
Athira Pharma Announces Pricing of Public Offering of Common StockAthira Pharma Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - January 20 at 10:18 PM
Athira Pharma Announces Proposed Public Offering of Common StockAthira Pharma Announces Proposed Public Offering of Common Stock
finance.yahoo.com - January 19 at 5:55 PM
Is ATHA A Good Stock To Buy According To Hedge Funds?Is ATHA A Good Stock To Buy According To Hedge Funds?
finance.yahoo.com - December 19 at 2:19 AM
What Type Of Shareholders Make Up Athira Pharma, Inc.s (NASDAQ:ATHA) Share Registry?What Type Of Shareholders Make Up Athira Pharma, Inc.'s (NASDAQ:ATHA) Share Registry?
finance.yahoo.com - December 18 at 6:18 AM
Athira Pharma Announces Appointment of Kelly A. Romano to its Board of DirectorsAthira Pharma Announces Appointment of Kelly A. Romano to its Board of Directors
finance.yahoo.com - December 14 at 8:04 AM
Athira Pharma Awarded $15 Million Grant from National Institute on Aging to Support ACT-AD Clinical Trial in Alzheimers DiseaseAthira Pharma Awarded $15 Million Grant from National Institute on Aging to Support ACT-AD Clinical Trial in Alzheimer's Disease
benzinga.com - December 8 at 4:24 PM
Athira Pharma Awarded $15 Million Grant from National Institute on Aging to Support ACT-AD Clinical Trial in Alzheimer’s DiseaseAthira Pharma Awarded $15 Million Grant from National Institute on Aging to Support ACT-AD Clinical Trial in Alzheimer’s Disease
finance.yahoo.com - December 8 at 9:15 AM
Dosing underway for Athira Pharmas ATH-1017 in mid-stage Alzheimers studyDosing underway for Athira Pharma's ATH-1017 in mid-stage Alzheimer's study
seekingalpha.com - December 1 at 5:18 PM
Athira Pharma Announces Initiation of Patient Dosing for ACT-AD Clinical Trial of ATH-1017, Small Molecule HGF/MET Activator, for Treatment of Mild-to-Moderate Alzheimer’s DiseaseAthira Pharma Announces Initiation of Patient Dosing for ACT-AD Clinical Trial of ATH-1017, Small Molecule HGF/MET Activator, for Treatment of Mild-to-Moderate Alzheimer’s Disease
finance.yahoo.com - December 1 at 7:56 AM
Athira Pharma IncAthira Pharma Inc
bloomberg.com - November 25 at 10:35 PM
Athira Pharma Reports Third Quarter 2020 Financial Results and Provides Business HighlightsAthira Pharma Reports Third Quarter 2020 Financial Results and Provides Business Highlights
finance.yahoo.com - November 12 at 4:53 PM
Athira Pharma to Present at Upcoming November Investor ConferencesAthira Pharma to Present at Upcoming November Investor Conferences
finance.yahoo.com - November 10 at 12:00 PM
Athira Pharma to Host Educational Webinar on the Predictive Nature of P300 to Determine Clinical Benefit of Alzheimer’s Disease TreatmentsAthira Pharma to Host Educational Webinar on the Predictive Nature of P300 to Determine Clinical Benefit of Alzheimer’s Disease Treatments
finance.yahoo.com - October 21 at 12:09 PM
Goldman Sachs: 2 Stocks That Could Climb Over 90%Goldman Sachs: 2 Stocks That Could Climb Over 90%
nasdaq.com - October 18 at 2:40 PM
Lumen Bioscience Announces Appointment of Dr. Mark Litton to Board of DirectorsLumen Bioscience Announces Appointment of Dr. Mark Litton to Board of Directors
finance.yahoo.com - October 8 at 8:09 AM
Athira Pharma Announces Initiation of Patient Dosing for the LIFT-AD Study, a Phase 2/3 Clinical Trial to Evaluate ATH-1017 for Treatment of Mild-to-Moderate Alzheimers DiseaseAthira Pharma Announces Initiation of Patient Dosing for the LIFT-AD Study, a Phase 2/3 Clinical Trial to Evaluate ATH-1017 for Treatment of Mild-to-Moderate Alzheimer's Disease
finance.yahoo.com - October 6 at 11:33 PM
Dosing underway in Athira Pharmas mid-stage Alzheimers study with ATH-1017Dosing underway in Athira Pharma's mid-stage Alzheimer's study with ATH-1017
seekingalpha.com - October 1 at 8:44 AM
Andreas Halvorsen Gets in on Athira Pharmas IPOAndreas Halvorsen Gets in on Athira Pharma's IPO
uk.finance.yahoo.com - September 29 at 7:18 PM
Athira Pharma, Inc. Rings the Closing Bell in Celebration of its IPOAthira Pharma, Inc. Rings the Closing Bell in Celebration of its IPO
nasdaq.com - September 29 at 7:18 PM
This page was last updated on 3/2/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.